Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2088 of 5804
-
Newborn fungal infection study tests two drugs head-to-head
Disease control CompletedThis study is designed to determine whether micafungin is as efficacious as the current standard of fluconazole, to compare the safety of the two drugs in the treatment of proven neonatal candidiasis. It is also designed to further elucidate the pharmacokinetics of the two produ…
Phase: PHASE2, PHASE3 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Jun 26, 2026 13:54 UTC
-
Can a common ADHD drug beat MS fatigue?
Symptom relief CompletedUp to 95% of individuals with Multiple Sclerosis report experiencing cognitive fatigue, characterized by a lack of energy, feelings of exhaustion, an the perception that one is unable to partake in daily activities. The goal of this project is to test whether methylphenidate (MP)…
Phase: PHASE2 • Sponsor: Kessler Foundation • Aim: Symptom relief
Last updated Jun 26, 2026 13:20 UTC
-
Cochlear implants for Single-Sided deafness: a Cost-Effective solution?
Disease control CompletedThe investigators assume that cochlear implants in this indication are not only effective but also cost-effective. The investigators' experimental protocol relies on real life therapeutic strategy, where a cochlear implant may be proposed once CROS and bone conductions systems ha…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a fixed T-Cell dose make stem cell transplants safer?
Disease control OngoingStem cells collected from sibling donors for allogenic transplants contain various types of cells. The predominant immune cells are called CD3+ T cells. The amount of these T cells vary vastly from donor to donor. This study is to determine if standardizing the CD3+ T cell dose w…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New study checks if botulism antidote is safe and effective for kids
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to verify the pediatric dosing recommendations for BAT product in pediatric patients that are treated with BAT product due to a confirmed or suspected case of botulism. A minimum of one serum sample should be collected but whenever feasible additional…
Phase: PHASE4 • Sponsor: Emergent BioSolutions • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New scan may reveal hidden Alzheimer's in stroke survivors
Diagnosis CompletedThis study is aimed at examining the interest of amyloid radiotracer Florbetapir (18F-AV-45) for the etiological diagnosis of poststroke cognitive impairment and dementia
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Hormones or surgery? new study tackles rectal endometriosis dilemma
Disease control CompletedThe purpose of this study is to determine whether, in women with deep endometriosis involving the rectum and not intending to get pregnant, continuous hormonal treatment would be followed by better digestive functional outcomes than curative rectal surgery. Are included women fro…
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could a depression drug fight prostate cancer?
Disease control CompletedThis phase II trial studies phenelzine sulfate in treating patients with prostate cancer that has not spread to other parts of the body and has come back. Phenelzine sulfate is a type of antidepressant that works by decreasing the amount of a protein called monoamine oxidase (MAO…
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
10-Year hip implant study shows how well it lasts
Disease control CompletedClinical and radiological 10 year results of Excia T® Hip Stem
Sponsor: Aesculap AG • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Brain zapping study aims to sharpen memory and focus across multiple disorders
Knowledge-focused Recruiting nowIn the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain.
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:49 UTC
-
Sound waves vs. Parkinson's: tiny trial tests brain zapping
Disease control CompletedThis is primarily a safety protocol to evaluate the safety of subthalamotomy using Transcranial ExAblate for treatment of Parkinson's Disease (PD) motor features.
Phase: NA • Sponsor: InSightec • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Exercise may boost memory in kids treated for brain cancer
Symptom relief CompletedBackground: \- More children with cancer are surviving into adulthood. Some side effects from treatment go away quickly. But some problems may not go away or may only show up months or years later. These problems are called late effects. Late effects can cause difficulties in co…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Home health visitors show promise for moms and kids in rural south africa
Disease control CompletedThe purpose of this early Phase 2 comparison trial is to evaluate the impact of community health worker (CHW) home visitors on pregnant women and their children in a rural setting in the rural Eastern Cape of South Africa. The intervention provided by the CHWs targets underweight…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Blood test may predict need for hip revision surgery
Diagnosis TerminatedThe purpose of the study is to develop a biomarker assay to be used as a diagnostic tool for adverse local tissue reaction, or tissue necrosis, in a metal on metal total hip replacement. A convenience sample of a total of 100 hip patients will be enrolled: 50 metal-on-metal revi…
Sponsor: OrthoCarolina Research Institute, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Battle of the bacteria: which h. pylori treatment wins?
Disease control Recruiting nowTo compare the eradication success rate between 10-days sequential therapy and 7-days tailored therapy based on H. pylori culture and antimicrobial susceptibility testing.
Phase: NA • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo pill could help diabetics on insulin
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of Canagliflozin (TA-7284) in combination with Insulin in patients with type 2 Diabetes for 16 weeks administration.
Phase: PHASE4 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New 9-Day combo shows promise for rare bone marrow disease
Disease control CompletedSevere acquired aplastic anaemia (SAA) is a bone marrow failure disease characterized by pancytopenia and a hypocellular bone marrow. The corn pathophysiological mechanism is the destruction of hematopoietic stem/progenitor cells mediated by auto-reactive effector T cells. Immuno…
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Gene map of tumors could personalize cancer therapy
Knowledge-focused Recruiting nowThis research trial studies using genomic profiling to recommend anticancer treatment to patients with cancer that has spread beyond the original site of the tumor (metastatic cancer). Genomic profiling studies the deoxyribonucleic acid (DNA) of a tumor to detect genetic changes …
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New drug combo aims to fight Hard-to-Treat prostate cancer
Disease control OngoingThe purpose of this study is to investigate potential drug-drug interaction (DDI) between JNJ-56021927 and abiraterone acetate and between JNJ-56021927 and prednisone, determine safety of the combination and evaluate in a descriptive manner the efficacy in these participants. It …
Phase: PHASE1 • Sponsor: Aragon Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Blood RNA may reveal hidden liver cancers
Diagnosis TerminatedThe study will examine and evaluate the use of extracellular RNA in blood as markers for the diagnosis of liver disease or cancer, and as markers for prediction of response to treatment or recurrence of cancer after surgery
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC